貓眼娛樂(01896.HK)授出40萬份受限制股份單位
格隆匯5月6日丨貓眼娛樂(01896.HK)公告,於2025年5月6日,公司根據受限制股份單位計劃的條款,向若幹僱員參與者授出400,000份受限制股份單位,相當於400,000股相關股份,佔於本公告日期已發行股份總數約0.035%。
授出受限制股份單位的目的乃就承授人爲促進公司的利益所作出的貢獻及不懈努力而向彼等提供激勵及獎勵,且授出受限制股份單位使承授人的利益與公司及股東的利益一致,並加強承授人對集團的承諾。公司認爲,授出受限制股份單位將會鼓勵及留住承授人爲集團的增長及發展作出持續貢獻,並符合公司及股東的利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.